Gunnar Boysen

Dr. Gunnar Boysen

University of Arkansas for Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
PJPIROON JENJAROENPUN
PIROON JENJAROENPUN
TWThidathip Wongsurawat
Thidathip Wongsurawat
TWTaylor D Wadley
Taylor D Wadley
TWTrudy Wassenaar
Trudy Wassenaar
JLJun Liu
Jun Liu
INIntawat Nookaew
Intawat Nookaew
Traditional epitranscriptomics relies on capturing a single RNA modification by antibody or chemical treatment, combined with short-read sequencing to identify its transcriptomic location. This approach is labor-intensive and may introduce experimental artifacts. Direct sequencing of native RNA using Oxford Nanopore Technologies (ONT) can allow for directly detecting the RNA base modifications, although these modifications might appear as sequencing errors. The percent Error of Specific Bases (%ESB) was higher for native RNA than unmodified RNA, which enabled the detection of ribonucleotide modification sites. Based on the %ESB differences, we developed a bioinformatic tool, epitranscriptional landscape inferring from glitches of ONT signals (ELIGOS), that is based on various types of synthetic modified RNA and applied to rRNA and mRNA. ELIGOS is able to accurately predict known classes of RNA methylation sites (AUC > 0.93) in rRNAs from Escherichiacoli, yeast, and human cells, using either unmodified in vitro transcription RNA or a background error model, which mimics the systematic error of direct RNA sequencing as the reference. The well-known DRACH/RRACH motif was localized and identified, consistent with previous studies, using differential analysis of ELIGOS to study the impact of RNA m6A methyltransferase by comparing wild type and knockouts in yeast and mouse cells. Lastly, the DRACH motif could also be identified in the mRNA of three human cell lines. The mRNA modification identified by ELIGOS is at the level of individual base resolution. In summary, we have developed a bioinformatic software package to uncover native RNA modifications.

1 August 2009 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
Gunnar BoysenGunnar Boysen
Gunnar Boysen
BPBrian F. Pachkowski
Brian F. Pachkowski
JNJun Nakamura
Jun Nakamura
JSJames A. Swenberg
James A. Swenberg

28 December 2007 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
JSJames A. Swenberg
James A. Swenberg
EFElizabeth Fryar-Tita
Elizabeth Fryar-Tita
YJYo-Chan Jeong
Yo-Chan Jeong
Gunnar BoysenGunnar Boysen
Gunnar Boysen
TSThomas Starr
Thomas Starr
RARichard J. Albertini
Richard J. Albertini

1 January 2003 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
Gunnar BoysenGunnar Boysen
Gunnar Boysen
SHStephen S Hecht
Stephen S Hecht

1 February 2007 in Kidney International
Verified
Journal Article
Open access
PDF file
NTN. Takahashi
N. Takahashi
Gunnar BoysenGunnar Boysen
Gunnar Boysen
FLF. Li
F. Li
YLY. Li
Y. Li
JSJ.A. Swenberg
J.A. Swenberg
Endogenous creatinine clearance (Ccr) is widely accepted as an estimate of glomerular filtration rate (GFR), the best overall biomarker of kidney function. However, current common methods of measuring creatinine are not sensitive enough for mouse plasma. Accordingly, we here report a new method of measuring creatinine by liquid chromatography tandem mass spectrometry (LC-MS/MS) using deuterated [2H3]-creatinine as an internal standard. The assay requires 10 μl or less of plasma or urine, and is eight times more sensitive than high-performance liquid chromatography. The reproducibility of the assay of replicates is approximately ±10%. The plasma creatinine levels of wild type male C57BL/6J mice obtained by LC-MS/MS are 0.076±0.002 mg/dl (n=65). To estimate daily urinary creatinine excretion for calculating Ccr, we collected urine from mice housed in metabolic cages, and combined this with washes from the cage internal surfaces. Creatinine in the wash varies from 4 to 67% of the total daily urinary creatinine excretion (typically ∼400 μg/day). Ccr obtained by LC-MS/MS was 329±17 μl/min, which is indistinguishable from GFR measured by using fluorescein isothiocyanate-inulin. The LC-MS/MS method is sensitive, specific, simple, fast, and inexpensive; it is suitable for estimating GFR in conscious mice or other small animals. As it allows repeated measurements in the same animals, it facilitates detection of subtle differences or changes in renal function.

1 April 2016 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
DSDaniel R. Sappington
Daniel R. Sappington
ESEric R. Siegel
Eric R. Siegel
GHGloria Hiatt
Gloria Hiatt
ADAbhishek Desai
Abhishek Desai
RPRosalind B. Penney
Rosalind B. Penney
Gunnar BoysenGunnar Boysen
Gunnar Boysen